The anxiety is manageable — it’s not clinical, not debilitating. But it’s there. That low-level tension that makes it hard to think clearly, that keeps you from sleeping as deeply as you should, that makes every meeting feel slightly higher-stakes than it is.
You’ve tried meditation, breathing exercises, maybe even a prescription that helped but came with side effects you didn’t love. Then you heard about Selank — a nasal peptide used in Russia for anxiety that supposedly works through the GABA system without the sedation or dependency of benzodiazepines. Here’s what the research actually shows.
Selank
Tuftsin Analog (Anxiolytic Nasal Peptide)
Also known as: Thr-Lys-Pro-Arg-Pro-Gly-Pro (Tuftsin analog)
Evidence Summary
- Strongest evidence for:
- Anxiety reduction (Stage III clinical trials completed in Russia, fMRI study in 52 healthy participants)
- Promising but early:
- Cognitive enhancement alongside anxiety reduction, immune modulation
- Mostly anecdotal:
- Long-term mood stabilization, creativity enhancement
- Key limitation:
- Like Semax, most research is Russian-language. Limited Western peer-reviewed data despite completed Stage III trials.
What It Is
Selank is a synthetic peptide based on tuftsin, an immune-modulating peptide. It acts primarily on GABAergic systems — the same systems targeted by benzodiazepines — but without sedation, tolerance buildup, or dependency risk. It also modulates serotonin and has demonstrated immune-modulating properties. Administered as a nasal spray. Approved in Russia for generalized anxiety disorder and neurasthenia.
What the Research Says
Anxiolytic Effects
T2: Emerging EvidenceStage III clinical trials completed in Russia for anxiety. A 2020 fMRI study in 52 healthy participants showed measurable changes in brain connectivity patterns associated with anxiety processing.
Cognitive Effects
T2: Emerging EvidenceThe anxiety reduction appears to unlock cognitive performance — less anxiety means clearer thinking. Some studies show direct nootropic effects beyond just anxiety reduction.
Immune Modulation
T3: Early / AnecdotalSelank is derived from tuftsin, which has known immune-modulating properties. Some evidence of enhanced immune function alongside cognitive effects.
GABA Mechanism
T2: Emerging EvidenceActs on GABA systems without the dependency profile of benzodiazepines. No tolerance buildup documented in Russian clinical use.
Without Western controlled human trials, we can’t fully verify that the clinical benefits demonstrated in Russian Stage III trials hold up to Western peer-reviewed scrutiny. The Russian approval is real, but regulatory approval in one country is not the same as proven by global RCT standards.
Typical Protocol
| Route | Nasal spray (no injection) |
| Dosage Range | 250–500 mcg/day |
| Frequency | 1–3 times daily |
| Cycle Length | 14–21 days, with breaks |
| Time to Effect | Anxiety reduction often within days; cognitive effects over 1–2 weeks |
| Note | Provider determines protocol. No injection required. |
Protocols vary by individual. Always follow your prescribing provider's instructions.
Risks & Side Effects
- Well-tolerated in Russian clinical use across thousands of patients.
- Nasal irritation — most commonly reported side effect.
- Mild fatigue — uncommon.
- No dependency, no withdrawal, no tolerance buildup documented — the key differentiator from benzodiazepines.
- Limited Western safety data.
Who Should Not Consider Selank
If you are currently on benzodiazepines or other GABAergic medications: Selank acts on the same broad neurotransmitter system as benzodiazepines, even though the mechanism is different and dependency has not been documented. Stacking GABAergic compounds without medical guidance can produce unpredictable effects on inhibitory neurotransmission. If you’re currently on a benzo and want to explore Selank as a transition tool, that is a conversation to have with your prescribing physician about a structured taper — not a swap to do on your own.
If you are pregnant or breastfeeding: No safety data exists in pregnant or lactating populations. Absolute contraindication.
If you have a bleeding disorder: Selank may affect coagulation pathways. The interaction is not well-studied, but anyone with hemophilia, von Willebrand disease, or who is on anticoagulant therapy should discuss with their hematologist before starting.
If you are looking to replace psychiatric medication without provider supervision: Selank is not a substitute for an SSRI, SNRI, or anxiolytic prescribed by a psychiatrist. Stopping a psychiatric medication unilaterally to try Selank is not biohacking — it is risk you don’t need to take. If you want to explore peptide-based anxiety support, do it as part of a coordinated plan with the physician managing your mental health, not in place of it.
Legal & Access Status
Category 2 but PCAC-referred since September 2024 — further along in reclassification than Semax. Approved pharmaceutical in Russia. Expected to return to Category 1.
Before You Start: Get Baseline Labs
We recommend baseline lab work before starting any peptide protocol so you and your provider can track changes. Key markers include IGF-1, fasting glucose, CBC, CMP and a thyroid panel.
Ask your provider about ordering these labs, or search for direct-to-consumer lab testing services in your area.
Lab recommendations are the same regardless of which service you use. See how we make money.
Questions for Your Provider
- 1I’m currently on [SSRI/benzo/other psychiatric medication] — is there an interaction concern?
- 2What’s the advantage of Selank over my current anxiety management approach?
- 3Do you recommend Selank alone or combined with Semax?
- 4How long should I trial it before we assess whether it’s working?
- 5Where do you source Selank, and is it legally compoundable given its PCAC-referred status?
Find a Provider
We’re finalizing our vetted provider list. Subscribe to be notified when provider recommendations go live.
When provider links go live, we’ll disclose all affiliate relationships here. See how we make money.
Stay ahead of the FDA.
Regulatory updates as developments happen. New compound profiles weekly. No spam. No sales pitches.